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Abstract
Rationale Ecstasy (±3,4-methylenedioxymethamphetamine)
is a widely used recreational drug that may damage the
serotonin system and may entail neuropsychological dysfunc-
tions.Fewstudiesinvestigatedpredictorsforecstasyuse.Self-
reported impulsivity does not predict the initiation of ecstasy
use; the question is if neuropsychological indicators of
impulsivity can predict first ecstasy use.
Objective This study tested the hypothesis that a neuropsy-
chological indicator of impulsivity predicts initiation of
ecstasy use.
Materials and methods Decision-making strategy and
decision-making reaction times were examined with the
Iowa Gambling Task in 149 ecstasy-naive subjects. The
performance of 59 subjects who initiated ecstasy use during
a mean follow-up period of 18 months (range, 11–26) was
compared with the performance of 90 subjects that
remained ecstasy-naive.
Results Significant differences in decision-making strategy
between female future ecstasy users and female persistent
ecstasy-naive subjects were found. In addition, the gap
between decision-making reaction time after advantageous
choices and reaction time after disadvantageous choices
was smaller in future ecstasy users than in persistent
ecstasy-naives.
Conclusion Decision-making strategy on a gambling task
was predictive for future use of ecstasy in female subjects.
Differences in decision-making time between future ecstasy
users and persistent ecstasy-naives may point to lower
punishment sensitivity or higher impulsivity in future
ecstasy users. Because differences were small, the clinical
relevance is questionable.
Keywords Ecstasy.MDMA.Decision-making.
IowaGamblingTask.Neuropsychology
Introduction
Ecstasy or ±3,4-methylenedioxymethamphetamine (MDMA)
is a popular recreational drug that is used by many teenagers,
adolescents, and young adults (Drugs Informatie en Moni-
toring Systeem 2006; El-Mallakh and Abraham 2007).
Given the extensive scientific literature suggesting sustained
harmful consequences of ecstasy use on the serotonin system
in the brain (Reneman et al. 2006;R i c a u r t ee ta l .2000)a n d
its neuropsychological correlates such as memory impair-
ment (Gouzoulis-Mayfrank and Daumann 2006;S c h i l te ta l .
2007), it seems desirable to investigate factors that predict
future ecstasy use.
A few studies focused on predictors for future ecstasy
use, looking either at internalizing factors such as anxiety
and depression or externalizing factors such as sensation
seeking and impulsivity. One prospective, population-based
study (Huizink et al. 2006) reported that symptoms of
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ecstasy in adolescence and adulthood. These findings are in
line with a retrospective study showing a strong association
between past-year depressive and panic symptoms and
recent-onset ecstasy use (Martins et al. 2006). In addition,
Lieb et al. (2002) reported that mental disorders precede
ecstasy use (Lieb et al. 2002). On the other hand, our own
prospective cohort study indicated that depressive symp-
toms did not predict future ecstasy use (de Win et al. 2006).
In addition, our prospective study failed to show self-
reported sensation seeking or impulsivity to predict future
ecstasy use (de Win et al. 2006). However, impulsivity is a
complex phenomenon which can be divided into different
aspects (Evenden 1999). For example, Patton et al. (1995)
distinguish motor impulsivity, cognitive impulsivity, and
non-planning impulsivity (Patton et al. 1995), whereas
Whiteside and Lynam (2001) describe aspects such as
urgency, (lack of) premeditation, (lack of) perseverance,
and sensation seeking (Whiteside and Lynam 2001). One
may not expect this complexity to be totally expressed in
self-report measures, and it is conceivable that other
measures, such as neuropsychological indicators of impul-
sivity, are more predictive of future ecstasy use. For example,
decision making or making choices may be considered as an
executive function in which behavioral inhibition and
impulsivity play a substantial role (Deakin et al. 2004;
Monterosso and Ainslie 1999). It has been proposed that
high impulsivity and risky decision making are factors that
might lead to drug use (Bechara and Damasio 2002;B e c h a r a
et al. 2001; Bolla et al. 2003; Ernst et al. 2003; Verdejo-
Garcia et al. 2008). Some developmental studies on risks for
alcohol abuse indeed show that mild executive dysfunctions
in children with familial risk for alcohol or substance
dependence enhance the risk for later addictions (Giancola
and Tarter 1999; Tarter et al. 2004).
To our knowledge, there are currently no prospective
studies on decision-making strategies before first ecstasy
use. There are some studies that examined decision making
in ecstasy users after the use of ecstasy because the
investigators reasoned that altered decision making could
be a sustained consequence of reduced serotonin availabil-
ity (Vollenweider et al. 2005; Morgan et al. 2006; Quednow
et al. 2007). Indeed, impaired decision making 90–120 min
after MDMA administration was reported in one study
(Vollenweider et al. 2005), but this was not replicated by
another study (Ramaekers and Kuypers 2006). Two other
studies showed impaired decision making in ecstasy users
after a minimal abstention period of 3–5 days (Morgan et
al. 2006; Quednow et al. 2007). However, no differences
between ecstasy users and controls were found after a
minimum abstention period of 2 weeks (Fox et al. 2002).
Instead of looking at the consequences of ecstasy use on
decision making, the current study focused on decision-
making strategy before the first use of ecstasy. A
neuropsychological measure of risk taking, the Iowa
Gambling Task, was used in a prospective cohort of at-
risk young adults. It was hypothesized that future ecstasy
users would show a more risky decision-making strategy on
the gambling task than persistent ecstasy-naives, which
should become visible in less advantageous choices and
shorter reaction times after losses in future ecstasy users
compared to persistent ecstasy-naives.
Materials and methods
This study is part of the larger Netherlands XTC Toxicity
Study investigating causality, course, and clinical relevance
of ecstasy neurotoxicity (de Win et al. 2005).
Participants and design
Between 2002 and 2004, 188 ecstasy-naive volunteers (18–
35 years) who considered starting ecstasy use in the near
future were recruited by targeted site sampling at colleges and
dance events, paper and website advertisements, and through
snowball sampling (Vervaeke et al. 2006). Exclusion criteria
were ecstasy use in the past (at baseline session); a serious
medical, neurological, or mental illness; use of medications
that may influence cognition; pregnancy; and intravenous
drug use. Subjects had to abstain from using psychoactive
substances for at least 2 weeks and from alcohol for at least
1 week prior to examination. Drug use during the days before
assessment was checked through urinalysis [enzyme-
multiplied immunoassay for amphetamines, MDMA, opiates,
benzoylecgonine (cocaine), benzodiazepines, 11-nor-Δ9-
THCCOOH, ethanol].
After inclusion, all subjects took part in neuropsycho-
logical assessment. Subjects had to complete validated
substance use questionnaires at baseline and thereafter
every 3 months during a mean follow-up period of
18 months (range, 11–26 months; Van de Wijngaart et al.
1997). Last-year use of alcohol (units/week), tobacco
(cigarettes/week), cannabis (number of joints), and amphet-
amines and cocaine (occasions) were measured.
Verbal intelligence was estimated because correlations
between IQ and performance on the Iowa Gambling Task
have been reported (Monterosso et al. 2001). For this
purpose, the Dutch version of the National Adult Reading
Test (Nelson and O’Connell 1978), the Dutch Adult
Reading Test (DART), was administered because it is
relatively insensitive to cognitive impairment caused by
neurological disorders (Schmand et al. 1991). As decision
making might be affected by mood (Must et al. 2006;
Taylor Tavares et al. 2007), also the Beck Depression
Inventory (BDI) was used to compare future ecstasy users
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(Beck and Steer 1984;B e c ke ta l .1961). The BDI is a 21-
item self-report rating inventory which measures character-
istic attitudes and symptoms of depression in the week prior
to assessment. Each item is scored 0 to 3, with higher scores
indicating more depressive symptoms. The BDI showed high
levels of reliability and validity (Beck and Steer 1984;
Bouman et al. 1985). Total BDI scores were calculated.
Scores higher than 13 are indicative for depression.
Subjects were paid for their participation (€100 or €150
per session depending on the number of assessments).
Besides the tests described in this paper, subjects took part
in more extensive neuropsychological testing and brain
imaging, which are described elsewhere (e.g., de Win et al.
2007; Jager et al. 2008; Schilt et al. 2007). The study was
approved by the local medical ethics committee. After
complete description of the study, each subject gave written
informed consent.
Assessments
Outcome variable: ecstasy use
Future first time ecstasy use was categorized in a binary
variable (yes=1, no=0).
Predictor variable: decision making
A computerized version of the Iowa Gambling Task was
used (Bechara et al. 1994, 1999). Four decks of cards are
displayed on a screen. Subjects have to choose a card from
one of the decks by selecting keyboard numbers 1, 2, 3, or
4. Each choice results in winning or losing money. Two of
the four decks give high rewards, but also high losses, and
result in a net loss in the long run (disadvantageous decks 1
and 2). The two other decks result in low rewards, but also
render lower losses, and result in a net gain in the long run
(advantageous decks 3 and 4). The explicit goal of the test
is to maximize profit on a loan of play money (Bechara et
al. 2000). Standard test instructions were used (Bechara et
al. 1999). Subjects were instructed to win as much money
as possible, and they were told that some decks were worse
than others but that they still could win if they avoided the
worst decks. Reaction time was measured after each trial.
Each deck consisted of 60 cards, and the task ended after
100 trials. The main measure for general performance was
the number of cards picked from the advantageous decks
(IGT performance). Because 14 subjects (9.4% of the total
sample) finished all the cards in one deck in the last stage
of the task, and would therefore bias the total IGT score, it
was decided to exclude the last 20 responses of all subjects
from the analyses. In addition, the mean difference in
decision-making reaction time after net wins and losses was
analyzed (dRT: RTwin minus RTloss), indicating reflection
following losses or negative feedback. Because the IGT
involves a learning component, most of the participants
learned to choose particular decks over time. Once subjects
have decks of preference, they will be less affected by wins
or losses, and therefore, reaction times after losses will
decrease during the course of the task. Consequently,
difference in reaction time (dRT) will change during the
course of the task. In a repeated measures analysis of
variance (ANOVA), with reaction time after losses as the
dependent measure and stage (stage 1 through 4) as the
within-subject factor, the effect of stage on reaction time
was significant: F2.04,301.47=18.14, p<0.001. For this
reason, a more valid measurement for reward/loss sensitivity
is dRT during the first three stages (0–60) of the task. The
first 60 responses were included in the analysis.
Statistical analyses
Unpaired t tests were performed to examine differences
between future ecstasy users and persistent ecstasy-naives in
age, DART-IQ, and BDI total score. Group differences in
gender were investigated using a chi-square test. In addition,
we investigated whether the two groups were similar in the
use of cannabis, alcohol, tobacco, cocaine, and amphetamine
prior to the use of ecstasy with non-parametric Mann–
Whitney tests. This is important because effects of substance
a b u s eo nd e c i s i o nm a k i n gh a v eb e e nr e p o r t e d( G o u d r i a a ne t
al. 2005, 2007; Grant et al. 2000;R o g e r se ta l .1999). We
also investigated whether drug use at baseline was associated
with IGT performance and dRT using Spearman’s r.
A multivariate logistic regression analysis was per-
formed with future ecstasy use (no=0, yes=1) as dependent
variable and the cognitive measures IGT performance and
dRT as predictor variables. Because some studies reported
sex differences in IGT general performance (Bolla et al.
2004; Reavis and Overman 2001), we also added gender
and the IGT performance by gender and dRT by gender
interaction terms as covariates together with DART-IQ and
substance use. Because of their skewed distribution, we
used the logarithmic transformation for the cannabis,
alcohol, and cigarette use variables. Since only a few
subjects used cocaine (11%) and a normal distribution
could not be reached after log transformation, this variable
was dichotomized (no use=0, use=1). Only one participant
used amphetamine. Therefore, separate analyses for the
effects of amphetamine use on decision-making strategies
were not performed. The subject was kept in the analyses;
excluding this subject from the analyses did not change any
of the results. In the multivariate logistic regression model,
DART-IQ, gender, and substance use were entered first.
After that, the cognitive measures were entered in order to
estimate the additive predictive value of these variables on
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tested using the tolerance factor (TF) and the variance
inflation factor (VIF).
All analyses were performed using SPSS statistical
software version 12.0.1 (SPSS, Chicago, IL, USA). Values
of p<0.025 were considered statistically significant
(Bonferroni correction).
Results
Of the 188 recruited subjects, we acquired sufficient
follow-up information on 149 volunteers (79%). Fifty-nine
subjects started using ecstasy during the follow-up period,
and 90 subjects remained ecstasy-naive. Reasons for not
trying ecstasy include: fear of acute effects, knowledge
about the harmfulness of the drug, and lack of opportunity.
For a detailed description of this part of the study, the
reader is referred to Vervaeke et al. (2008). Follow-up
information of the other subjects was missing either
because the volunteers did not want to participate in the
follow-ups or because we could not reach them anymore.
The group of subjects that dropped out had a significantly
lower estimated DART-IQ (difference of five points
between included subjects and dropouts). Age, sex distri-
bution, and drug use did not differ significantly between
dropouts and included subjects.
Demographics and substance use characteristics of the
included subjects are shown in Table 1. The groups were
similar in terms of gender distribution, age, DART-IQ, and
BDI sum score. Drug use did not differ significantly between
future ecstasy users and persistent ecstasy-naive subjects.
Iowa Gambling Task
A first exploration of Spearman’s correlations between the
use of substances other than ecstasy and IGT performance
and dRT, respectively, showed only a significant negative
correlation between cocaine (number of times last year) and
the number of advantageous deck choices (Spearman’s r=
−0.28, p<0.001): More cocaine use was associated with
worse deck choices. However, cocaine use ever was not
significantly associated with future ecstasy use [χ
2(1)=
2.97, p=0.09].
A logistic regression model with DART-IQ, gender, and
substance use as independent variables did not significantly
predict future ecstasy use [χ
2(6)=7.57, p=0.27]. In the next
step, the cognitive measures (IGT performance and the IGT
performance by gender, dRT, and dRT by gender interaction
terms) were added to the model. This improved the ability of
the model to predict future ecstasy use significantly
[χ
2(4,10)=16.27, p<0.01] and added 13.3% (Nagelkerke
R
2) to the explained variation of the model. Because the dRT
by gender interaction term was not significant (p>0.10), this
term was removed from the model (Hosmer and Lemeshow
2000). Repeated analysis showed that IGT performance, IGT
performance × gender, and dRT still improved the predictive
ability of the model significantly [χ
2(3,9)=15.28, p<0.01]
with 12.5% (Nagelkerke R
2). In our model, multi-collinearity
was not an issue (TF 0.73–0.97, VIF 1.03–1.37). The
regression coefficients of IGT performance or gender cannot
be interpreted as main effects in a model with a significant
IGT by gender interaction term. However, separate analysis
without the interaction factor showed no significant effects of
gender or IGT performance. For the significance of the
predictors, we looked at IGT performance by gender
interaction and dRT. The beta coefficients indicated that less
advantageous deck choices in female participants and smaller
differences in reaction times after wins and losses (in males
and females) resulted in a higher likelihood of future ecstasy
use (see Figs. 1 and 2 and Table 2).
Figure 2 shows that primarily, the reaction times after
losses differed between the two groups, with persistent
ecstasy-naives having longer reaction times after losses than
Table 1 Characteristics of demographics and substance use (N=149)
Future ecstasy users (N=59) Persistent ecstasy-naives (N=90) p values
Gender (M/F%) 25 M, 34 F (42/58%) 38 M, 52 F (42/58%) 0.99
a
Age 21.4±2.8 21.7±2.5 0.58
b
DART-IQ 104.1±9.2 105.2±9.5 0.47
b
BDI 3.9±3.8 3.2±3.3 0.21
b
Alcohol (units/week) 9.1±7.5 9.0±9.0 0.66
c
Tobacco (cigarettes/week) 34.1±49.2 26.7±52.0 0.07
c
Cannabis (joints last year) 36.8±64.8 19.4±37.6 0.09
c
Amphetamine (times last year) 0.0±0.0 0.6±5.5 0.42
c
Cocaine (times last year) 1.0±2.3 0.5±1.6 0.09
c
Values expressed as mean±SD
aPearson chi-square
bANOVA
cMann–Whitney
522 Psychopharmacology (2009) 203:519–527future ecstasy users. The overall classification accuracy of
the whole model was 66.4%, with a negative predictive
accuracy of 80% (persistent ecstasy-naives correctly classi-
fied in the ecstasy-naive group) and a positive predictive
accuracy of 46% (future ecstasy users correctly classified in
the future ecstasy use group).
Discussion
The current study prospectively investigated the association
between decision-making strategy and future first ecstasy
use. We hypothesized that a risky decision-making strategy
on a gambling task would predict future first ecstasy use. In
our study population, only in female participants was a
relationship found between decision-making strategy and
future ecstasy use: Less advantageous deck choices on a
gambling task resulted in a higher likelihood of future first
ecstasy use. In addition, decision-making reaction time
differed significantly between the total group of persistent
ecstasy-naives and the total group of future ecstasy users:
Future ecstasy users did not prolong their reaction times
after punishments, whereas persistent ecstasy-naives did.
A possible explanation for the finding that decision-
making strategy only was predictive for future ecstasy use
in women and not in men might be sought in differences in
working memory capacity. Some studies postulate a role for
working memory in decision making (Bechara and Martin
2004; Pecchinenda et al. 2006), and therefore, it could be
theorized that the disadvantageous responses in female
subjects of our study sample are due to a decreased working
memory. At first sight, there are indications that this is true
because in our previous study in the same cohort, female
future ecstasy users showed lower scores on working
memory tasks than male future ecstasy users (Schilt et al.
2007). However, after correction for DART-IQ and sub-
stance use, differences turned out to be non-significant (p>
0.17). Consequently, it seems unjustified to ascribe the
differences in decision-making performance between male
and female future ecstasy users to differences in working
memory.
Possibly, initiation of ecstasy use in men is influenced by
other factors than in women. In men, external factors like
peer influence or availability of opportunities may play a
greater role in the initiation of ecstasy use than in women
(Van Etten et al. 1999), while in women, the start of using
ecstasy might be regulated by more internal factors, like
personality characteristics or decision-making strategies. In
The Netherlands, the percentage of the population (age 15–
64) that ever used ecstasy was higher in men than in
women (3.7% versus 2.1% in 2001 and 6.6% versus 1.2%
in 2005; Drugs Informatie en Monitoring Systeem 2006),
suggesting that for men, ecstasy use is a less unusual thing
to do than for women. Women might need to show more
deviant behavior to take the first step to ecstasy use.
The finding that future ecstasy users did not prolong their
reaction time after punishment may imply higher impulsivity
and/or lower punishment sensitivity. Higher impulsivity was
also put forward by Goudriaan et al. (2006) as a possible
explanation for a lack of difference in reaction time after
rewards or after punishments in alcohol-dependents
(Goudriaan et al. 2006). However, in our study population,
future ecstasy users did not report higher impulsivity on a
self-report impulsiveness scale (de Win et al. 2006). This
could be due to the lack of an association between self-
reported impulsivity and decision-making scores (data not
shown). Other studies also failed to find a significant
relationship between self-report impulsivity scales and
performance on the Iowa Gambling Task (Franken and
Muris 2005; Goudriaan et al. 2007; Jollant et al. 2005,
2007). Three other studies, however, did find significant
correlations between self-reported impulsivity and perfor-
mance on the Iowa Gambling Task (Christodoulou et al.
2006; Franken et al. 2008; Zermatten et al. 2005), but in two
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used other than the Barratt Impulsiveness Scale (BIS) used in
our study. Possibly, the BIS does not capture the kind of
impulsivity that is measured with the Iowa Gambling Task.
As stated in “Introduction”, impulsivity is a complex
construct that consists of different dimensions (Evenden
1999). In the study of Zermatten (2005) for example, it
appeared that only “premeditation” (thinking at forehand
about a future action), as part of impulsivity, was related to
decision making (Zermatten et al. 2005). Dawe and Loxton
(2004) mentioned in their review an association between
decision making and “rash unplanned impulsivity” rather
than “reward sensitivity/drive” (Dawe and Loxton 2004).
The fact that we did not find indications for self-reported
impulsivity as an explanation for the shorter reaction times
after losses in future ecstasy users does not mean that there is
no connection between certain aspects of impulsivity and
IGT performance. Instruments other than the self-report
questionnaires used in the current study are needed to
investigate this more thoroughly.
The results of this study possibly reflect lower punish-
ment sensitivity in future ecstasy users. Individuals that
start to use ecstasy may be less sensitive to the possible
negative consequences of their choice. Although some
studies did not find an association between substance
misuse and sensitivity to punishment (Jorm et al. 1998;
Leland and Paulus 2005), other studies showed that poor
conditioning to signals for punishment is associated with an
increased risk of alcohol abuse. This may be a reflection of
a weak behavioral inhibition system (Finn et al. 1994;
Loxton and Dawe 2001; Loxton et al. 2008). Subjects with
low punishment sensitivity may be more prone to try
ecstasy because they do not consider the potential negative
consequences of drug use.
Some limitations of this study should be mentioned. An
important limitation of this study is the selection of the
participants. Subjects were selected on the basis of their self-
reported wish to start using ecstasy in the near future.
Consequently, our study sample was not representative of the
general population, which limits the generalizability of the
results. This selection process could explain the small effect
sizes and lack of associations between decision-making
performance and self-report impulsivity questionnaires.
Although the effect size for difference in IGT performance
between female ecstasy-naives and female future ecstasy
users was moderate (Cohen’s d=0.50), the effect size for
dRT between ecstasy-naives and future ecstasy users was
rather small (Cohen’s d=0.37). Another limitation is that we
do not know if the persistent ecstasy-naive subjects would
remain ecstasy-naive after the follow-up period of our study
(11–26 months). Therefore, our results only provide infor-
mation about prediction of ecstasy use in the near future, but
not of ecstasy use ever. The current study provides only
limited support for the use of neuropsychological decision-
making tests in the prediction of initial ecstasy use. In
contrast, neuropsychological measures of executive func-
tioning and decision-making strategies appear to be stronger
predictors for relapse in substance dependence or addictive
behaviors (Bowden-Jones et al. 2005; Dallery and Raiff
2007; Goudriaan et al. 2008;P a u l u se ta l .2005). Moreover,
neuropsychological tests other than the decision-making test
used in our study might capture certain aspects of impulsiv-
ity better and subsequently could be superior predictors for
future ecstasy use. Perhaps, other factors that we did not
include in our study could better predict future ecstasy use.
Some studies point at cannabis use as a risk factor for later
ecstasy use (de Win et al. 2006; Martins et al. 2007;
Pedersen and Skrondal 1999;Z i m m e r m a n ne ta l .2005).
However, in the current study, cannabis and cocaine use did
not significantly predict future ecstasy use. Possibly, the use
of other drugs is especially predictive for frequent ecstasy
use rather than for the first incidence of low-dose ecstasy use
(mean ecstasy use at final evaluation was 6.3 pills, SD 12.1,
median 2.0).
In summary, in this study, decision-making strategy was
predictive for first incidental use of ecstasy in female
Table 2 Prediction of IGT performance and difference in reaction time after IGT wins and losses (dRT) on future first ecstasy use
B SE Wald statistics p value OR 95% CI
DART-IQ −0.01 0.02 0.14 0.71 0.99 0.95–1.03
Sex −5.19 1.70 9.35 0.00 0.01 0.00–0.16
Cannabis (joints last year)
a 0.17 0.11 2.26 0.13 1.18 0.95–1.48
Cocaine (use/no use last year) 1.12 0.65 2.96 0.09 3.08 0.86–11.06
Alcohol (units/week)
a −0.09 0.22 0.15 0.70 0.92 0.60–1.41
Tobacco (cigarettes/week)
a 0.04 0.09 0.20 0.65 1.04 0.88–1.24
IGT performance −0.06 0.03 5.24 0.02 0.94 0.90–0.99
IGT performance × sex 0.11 0.04 9.19 0.00 1.11 1.04–1.20
dRT −0.00 0.00 5.59 0.02 0.99 0.99–1.00
OR odds ratio, CI confidence interval
aLog-transformed
524 Psychopharmacology (2009) 203:519–527participants within the 11–26 months following baseline
assessment. Furthermore, decision-making reaction time
differed between future ecstasy users and persistent ecstasy-
naives. However, the clinical relevance is limited because
effect sizes were small to moderate only. It is conceivable
that decision-making strategy is more important in the
continuation of ecstasy use than in the initiation of first
low-dose ecstasy use. Therefore, it is important to follow
this study cohort and to compare decision-making strategy
(before first ecstasy use) in the subjects that become
frequent ecstasy users with persistent ecstasy-naives.
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